Best Etf To Buy 2018 Review

While still a giant, many investors now prefer the XBI (SPDR S&P Biotech) for its equal-weight approach to smaller, high-growth companies. 3. Short-Term Treasury & Cash (The Safety Net)

Healthcare often acts as a "defensive" sector during volatility. In 2018, breakthroughs in gene therapy boosted specific biotech ETFs. iShares Nasdaq Biotechnology ETF (IBB) best etf to buy 2018

2018 was a volatile year for the market, characterized by trade tensions and rising interest rates. The "best" ETFs that year generally fell into three categories: While still a giant, many investors now prefer

Are you looking to compare these against current 2026 market leaders , or are you researching for a specific long-term portfolio analysis? In 2018, breakthroughs in gene therapy boosted specific

Buying the 2018 dip led to massive gains in 2019-2021. Tech (QQQ) Volatile, but stayed flat/positive. Winner. The dominant theme of the last decade. Dividends (VYM) Struggled due to rising rates. Moderate. Better for income than raw growth. The "Best" Pick in Hindsight

If you had bought the in 2018, you would have captured the beginning of the massive run-up in Big Tech (Apple, Microsoft, Amazon) that defined the early 2020s.

Investors pivoted toward "subscription-based" business models that proved resilient.